FindTrial
Sign In

Usefulness of postoperative adjuvant chemotherapy in patients with colorectal cancer T1/T2, N(+)

Usefulness of postoperative adjuvant chemotherapy in patients with colorectal cancer T1/T2, N(+) - Usefulness of postoperative adjuvant chemotherapy in patients with colorectal cancer T1/T2, N(+)

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000047044
Enrollment
621
Registered
2022-03-01
Start date
2022-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon cancer

Interventions

None listed

Sponsors

Japanese Foundation for Multidisciplinary Treatment of Cancer
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with T1 / T2 and N (+) among all enrolled clinical studies conducted by JFMC in the past (JFMC7 / JFMC15 / JFMC33 / JFMC35 / JFMC37 / JFMC38 / JFMC41)

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

MeasureTime frame
overall survival relapse-free survival disease-free survival Time-to-treatment-failure—

Countries

Japan

Contacts

Public ContactYukari/Masaru Kawamura/Mutoh

Japanese Foundation for Multidisciplinary Treatment of Cancer Data Management Section/Statistical Analysis Section

jfmc-dc@jfmc.or.jp0356277594

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026